The aim of this thesis was to analyse EpCAM expression in gastroentero-pancreatic (GEP)
neuroendocrine neoplasia (NEN) and the potential role of EpCAM as a prognostic indicator …

Purpose: Neuroendocrine tumors (NET) are heterogeneous tumors with widely variable
survival. It is unknown whether they express EpCAM (epithelial cell adhesion molecule) and …

Aims: Pancreatic adenocarcinoma is an aggressive gastrointestinal malignancy with only a
few long-term survivors even after radical surgery. Patients with ampullary cancer have a …

Background: Aim of the study was to assess the diagnostic and prognostic impact of serum
EpCAM levels in patients with pancreatic adenocarcinoma (PDAC). Materials and Methods …

Abstract Background The association of EpCAM expression with the progression of gastric
cancer remains unclear. Here, we investigated the expression of EpCAM in gastric cancer …

Objective EpCAM (CD326) is overexpressed in progenitor cells of endocrine pancreatic
islands of Langerhans during fetal development and was suggested to act as a …

AIM: EpCAM (CD326) is a transmembrane glycoprotein on epithelial cells. To assess its
expression, an increasing number of commercially available antibodies combined with …

The identification of reliable prognostic markers that distinguish patients' status and predict
therapeutic response can improve the clinical outcomes of pancreatic cancer patients. The …

Aims Epithelial cell adhesion molecule (EpCAM) is a cell surface protein with oncogenic
features that is expressed on healthy human epithelia and corresponding malignant …

The identification of molecular markers useful for predicting prognosis in pancreatic cancer
patients is crucial for advances in disease management. The epithelial cell adhesion …